Orka Two vs Otofonix Encore

The Orka Two is a behind-the-ear prescription hearing aid priced at $1,899, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This places it in the top 67% of the 36 prescription hearing aids we've evaluated, ranking #25 in its category. In our testing, the Orka Two shows a mixed performance profile with clear strengths and weaknesses. Music streaming stands out at 3.3/5, measuring 0.66 points above the category average—a solid result for users who prioritize phone audio quality. Own-voice comfort also performs well at 3.2/5, sitting 0.45 points above average, which may contribute to a more natural listening experience. Feedback handling is excellent at 5.0/5, among the best we've measured. However, speech-in-noise performance is a notable limitation. At 1.4/5, it falls 0.56 points below the category average—a low absolute score that may affect understanding in challenging listening environments like restaurants or group conversations. Speech in quiet fares better at 3.7/5, measuring 0.40 points above average. The Orka Two may suit users who prioritize streaming quality, own-voice comfort, and stability over speech-in-noise performance. Those frequently in noisy environments should note that competitors in this price range, such as the Rexton Reach R-Li T80 at Costco (4.58/5), deliver stronger overall scores. Budget-conscious shoppers might also consider lower-priced alternatives like the Sony CRE-C10, which scored 4.19/5 in our testing.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.